Join OBN to learn more about the OBN Awards 2020 finalists for Best Established Biotech Company:
Absolute Antibody – who has developed a proprietary manufacturing platform based on transient transfection for the production of sequenced and engineered antibodies, AbsoluteAbs (AbAbs)
C4X Discovery – exploit cutting edge technologies to design and create small-molecule candidates in a range of therapeutic areas
Exscientia - automate drug discovery and design processes leveraging artificial intelligence and big data
John will interview each finalist in turn, aiming to share more about the company’s story, their R&D Innovation and why they are making such an impact on the industry today. We will also hear a few words from our sponsor, Precision for Medicine who are kindly supporting and presenting this award category.
Click here to register (waiting for link)
The OBN Awards, are the most highly regarded awards event in the industry and aim to recognise and celebrate the most innovative life sciences companies across all therapy areas and functions.